Source:http://linkedlifedata.com/resource/pubmed/id/19399995
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
2009-4-27
|
| pubmed:abstractText |
Mycophenolate mofetil (MMF) is an alternative to cyclophosphamide for the treatment of lupus nephritis. The precise role of MMF is under ongoing evaluation. This review provides an up-to-date summary of MMF and its use as remission induction and maintenance therapy for lupus nephritis.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
1531-6963
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
21
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
256-61
|
| pubmed:meshHeading |
pubmed-meshheading:19399995-Clinical Trials as Topic,
pubmed-meshheading:19399995-Cyclophosphamide,
pubmed-meshheading:19399995-Humans,
pubmed-meshheading:19399995-Immunosuppressive Agents,
pubmed-meshheading:19399995-Lupus Nephritis,
pubmed-meshheading:19399995-Mycophenolic Acid,
pubmed-meshheading:19399995-Remission Induction
|
| pubmed:year |
2009
|
| pubmed:articleTitle |
What is the value of mycophenolate mofetil as induction and maintenance therapy in lupus nephritis?
|
| pubmed:affiliation |
Renal Unit, Vasculitis and Lupus Clinic, Box 118, Addenbrooke's Hospital, Hills Road, Cambridge CB2 OQQ, UK.
|
| pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|